TMS Co., Ltd. engages in the research and development of pharmaceutical products and medical devices. It focuses on a family of compounds called Stachybotrys microspora triprenyl phenol (SMTPs). The company was founded by Keiji Hasumi on February 17, 2005 and is headquartered in Tokyo, Japan.